Lazurite® to Exhibit ArthroFree® Wireless Camera System at AANA Courses on Oct. 20-22 and Nov. 3-4
Ohio Pen/10240259

Trending...
Download
Surgeons attending two upcoming AANA lab courses will have the opportunity to try out Lazurite's ArthroFree wireless camera for themselves. ArthroFree has been used in centers of excellence around the country with outstanding results. (Photo: Business Wire)
CLEVELAND--(BUSINESS WIRE)--Medical device and technology company Lazurite® announced that its ArthroFree® Wireless Camera System will be available at the Arthroscopy Association of North America (AANA) Advanced Knee and Shoulder course on Oct. 20-22, and the Innovations in Hip Arthroscopy lab course on Nov. 3-4, at the AANA Orthopaedic Learning Center in Rosemont, Illinois.

More on Ohio Pen
At the Advanced Hip Arthroscopy course, Shane J Nho, M.D., M.S. of Gold Coast Surgery Center and Rush University Medical Center in Chicago will use the ArthroFree system to teach a labral reconstruction at 1:30 p.m. Central Time.

At both events, an ArthroFree device will be on display and available to try in the exhibit area. At the Hip and Knee event there also will be an ArthroFree at the lab checkout station. Surgeons can review the ArthroFree system there and bring it to their cadaver station on a cart to try it out.

"We invite attendees to try the ArthroFree camera system at these AANA courses to see what it means to operate when there is no cord to distract your attention or limit your dexterity," Lazurite CEO and co-founder Eugene Malinskiy said.

For surgeons who want to be at the top of their game for every procedure, the ArthroFree wireless camera system has no cord to distract a surgeon's attention or limit dexterity so they can enhance their focus on the patient's procedure. ArthroFree has been used in centers of excellence around the country with outstanding results. For more information, contact an ArthroFree product expert at: (833) 214-2324 or contact@lazurite.co.

About AANA

The Arthroscopy Association of North America offers hands-on cadaver lab courses to meet the unique needs of a variety of career stages. For more information, visit www.aana.org

About Lazurite

Lazurite designs medtech devices. Its ArthroFree® System is the first wireless camera with FDA clearance for arthroscopy and general endoscopy. The ArthroFree System is designed to enhance the surgeon's focus during the critical moments of surgery by enabling untethered movement and dexterity. It promises to increase the safety and efficiency of minimally invasive surgical procedures while decreasing the cost. Lazurite's IP portfolio includes the high-efficiency Meridiem® light technology, wireless communication technology, and products in development. Lazurite's three-year vision (by 2026): Modernize 1,000 operating rooms for the wireless age. For more information, see https://lazurite.co.

Forward-Looking Statements

This press release includes "forward-looking statements." Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "projected," "estimate," "expect," "may," "should," "will," "designed," "optimistic," "promises," "helps," "allows" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the expected impact and ease of use advantages of the ArthroFree System within the field of minimally invasive surgery, particularly orthopedic surgery. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

More on Ohio Pen
Lazurite®, ArthroFree®, and Meridiem® are registered trademarks of Lazurite Holdings LLC.

Media Center

Visit lazurite.co/media for videos, logos, images, fact sheets, bios and more.

Contacts

Patrick Gallagher
+1 (216) 233-7473
p.gallagher@lazurite.co

Lazurite:
+1 (216) 334-3127
contact@lazurite.co

0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>

#Hashtags
  • #innovation (https://twitter.com/hashtag/innovation?src=hash)
  • #ortho (https://twitter.com/hashtag/ortho?src=hash)
  • #ohiotech (https://twitter.com/hashtag/ohiotech?src=hash)
  • #medtechnews (https://twitter.com/hashtag/medtechnews?src=hash)
  • #medtech (https://twitter.com/hashtag/medtech?src=hash)
  • #arthroscopy (https://twitter.com/hashtag/arthroscopy?src=hash)
  • #devices (https://twitter.com/hashtag/devices?src=hash)
  • #wireless (https://twitter.com/hashtag/wireless?src=hash)
  • #orthopedic (https://twitter.com/hashtag/orthopedic?src=hash)
  • #orthopedicsurgeon (https://twitter.com/hashtag/orthopedicsurgeon?src=hash)
  • #medicaldevice (https://twitter.com/hashtag/medicaldevice?src=hash)
  • #thehealthcaretechnologyreport (https://twitter.com/hashtag/thehealthcaretechnologyreport?src=hash)
  • #medicaldevices (https://twitter.com/hashtag/medicaldevices?src=hash)
  • #minimallyinvasive (https://twitter.com/hashtag/minimallyinvasive?src=hash)
  • #endoscope (https://twitter.com/hashtag/endoscope?src=hash)
  • #startup (https://twitter.com/hashtag/startup?src=hash)
  • #outpatientsurgery (https://twitter.com/hashtag/outpatientsurgery?src=hash)
  • #whenyouimagine (https://twitter.com/hashtag/whenyouimagine?src=hash)
  • #Biomedevice (https://twitter.com/hashtag/Biomedevice?src=hash)
  • #healthinnovation (https://twitter.com/hashtag/healthinnovation?src=hash)
  • #endoscopy (https://twitter.com/hashtag/endoscopy?src=hash)
  • #orthotech (https://twitter.com/hashtag/orthotech?src=hash)
  • #arthroscopic (https://twitter.com/hashtag/arthroscopic?src=hash)
  • #emerging (https://twitter.com/hashtag/emerging?src=hash)
  • #surgery (https://twitter.com/hashtag/surgery?src=hash)
  • #venturecap (https://twitter.com/hashtag/venturecap?src=hash)
  • #surgeon (https://twitter.com/hashtag/surgeon?src=hash)
  • #surgicaltech (https://twitter.com/hashtag/surgicaltech?src=hash)
  • #sportsmedicine (https://twitter.com/hashtag/sportsmedicine?src=hash)
  • #ambulatorysurgery (https://twitter.com/hashtag/ambulatorysurgery?src=hash)
  • #healthcaretechnology (https://twitter.com/hashtag/healthcaretechnology?src=hash)
  • #endoscopic (https://twitter.com/hashtag/endoscopic?src=hash)

Social Media Profiles
  • Lazurite on Twitter (https://twitter.com/LazuriteLabs)
  • Lazurite on LinkedIn (https://www.linkedin.com/company/lazuritelabs/)

Contacts

Patrick Gallagher
+1 (216) 233-7473
p.gallagher@lazurite.co

Lazurite:
+1 (216) 334-3127
contact@lazurite.co
Filed Under: Business
Show All News | Report Violation

0 Comments

Latest on Ohio Pen